This disclosure describes new antibiotic Cytosporacin having the structure:
##STR1##
The invention relates to a new antibiotic designated Cytosporacin, to its
production by fermentation, to methods for its recovery and concentration
from the crude solutions, and to process for its purification. The
invention includes within its scope the agent in dilute form, as a crude
concentrate, and in pure form. The invention also relates to the use of
the compound according to the invention in antimicrobial compositions and
as antiseptics or disinfectants.
